Clinical blood draw for Galleri cancer screening
Advanced Diagnostics

Screen for 50+ Cancers With a Single Blood Draw

The Galleri® multi-cancer early detection test identifies a unique DNA "fingerprint" of cancer cells in your bloodstream — catching signals before symptoms ever appear.

The Silent Threat

Most Cancers Are Found Too Late

Standard screenings only cover 5 cancer types — breast, cervical, colorectal, lung, and prostate. That leaves the vast majority of cancers with no recommended screening test at all. By the time symptoms appear, cancer has often already progressed to later stages.

0%+

Of cancer deaths come from types with no standard screening

0+

Cancer types the Galleri test screens for in a single blood draw

~0%

Of Galleri test-takers receive a 'No Cancer Signal Detected' result

The Science

How the Galleri Test Works

1

Simple Blood Draw

A standard blood sample is collected — just like routine labs. No fasting. No special preparation. Done right here at Mend Medical.

2

Methylation Analysis

The GRAIL laboratory analyzes hundreds of thousands of DNA methylation sites in your cell-free DNA — fragments naturally shed by cells into your bloodstream.

3

Cancer Signal Detection

Advanced machine learning identifies unique methylation patterns — the "fingerprint" distinguishing cancer-derived DNA from normal DNA across 50+ cancer types.

4

Signal Origin Prediction

If a cancer signal is detected, the test predicts the tissue type or organ where the signal originates — giving your physician a clear starting point for diagnostic follow-up.

Comprehensive Coverage

One Test.
50+ Cancer Types.

The Galleri test screens for a shared cancer signal across more than 50 cancer types — including many of the 12 deadliest cancers responsible for approximately two-thirds of all cancer deaths.

Highlighted cancers below are among the types responsible for the majority of cancer-related deaths and currently have no standard screening protocol.

PancreaticLiverLungOvarianStomachEsophagealBladderKidneyLymphomaLeukemia

Full Test Coverage — 50+ Cancer Types

Adrenal Cortical Carcinoma
Ampulla of Vater
Anus
Appendix Carcinoma
Bile Ducts (Distal)
Bile Ducts (Intrahepatic)
Bile Ducts (Perihilar)
Bladder
Bone
Breast
Cervix
Colon & Rectum
Esophagus
Gallbladder
GI Stromal Tumor
Gestational Trophoblastic
Kidney
Larynx
Leukemia
Liver
Lung
Lymphoma (Hodgkin)
Lymphoma (Non-Hodgkin)
Melanoma
Merkel Cell Carcinoma
Mesothelioma
Nasal Cavity
Nasopharynx
Neuroendocrine (Pancreas)
Neuroendocrine (Colon)
Oral Cavity
Oropharynx
Ovary / Fallopian Tube
Pancreas
Penis
Plasma Cell Myeloma
Prostate
Small Intestine
Soft Tissue Sarcoma
Stomach
Testis
Ureter / Renal Pelvis
Uterus (Carcinoma)
Uterus (Sarcoma)
Vagina
Vulva
Clinical Evidence

Backed by the Most Rigorous Science

The Galleri test was developed by GRAIL and evaluated in clinical studies with over 20,000 participants. The laboratory is certified by CLIA and accredited by the College of American Pathologists.

0+

Clinical study participants across multiple published trials

0.0%

False positive rate — among the lowest of any multi-cancer detection test

0.0%

Cancer Signal Origin prediction accuracy in confirmed diagnoses

Cleveland ClinicDana-Farber Cancer InstituteMemorial Sloan KetteringMayo ClinicSutter HealthIntermountain Healthcare

The Galleri test has been studied in collaboration with leading cancer institutes and health systems.

Eligibility

Who Should Consider the Galleri Test?

The Galleri test is recommended for adults with an elevated risk for cancer, particularly those age 50 and older. It is designed to complement — not replace — your existing recommended screenings.

  • Adults age 50 and older
  • Individuals with a family history of cancer
  • Those seeking proactive, preventive health screening
  • Patients who want to go beyond standard cancer screenings
  • Anyone committed to a longevity-focused health strategy
Not Recommended For
  • Individuals under 21 years of age
  • Those currently pregnant
  • Patients undergoing active cancer treatment

The Galleri test does not detect all cancers and should be used in addition to routine cancer screenings recommended by your healthcare provider. A "No Cancer Signal Detected" result does not rule out cancer.

Your Screening

Invest in Knowing

Galleri® Multi-Cancer Early Detection Test

$849
HSA / FSA Eligible·Results in ~2 Weeks
  • Physician-ordered blood test through Mend Medical
  • Screening for 50+ cancer types from a single blood draw
  • Cancer Signal Origin prediction if a signal is detected
  • Comprehensive results review with your Mend physician
  • Personalized follow-up care plan and next steps

Most health insurance plans do not cover the Galleri test. Mend Medical offers this as a self-pay service. Payment is collected at time of booking.

The Mend Advantage

Why Patients Choose Mend Medical

Physician-Guided Experience

Your test is ordered and reviewed by a Mend physician who knows your full health history — not a random telehealth provider. Results are interpreted in the context of your complete health picture.

Integrated Into Your Longevity Plan

Your Galleri results don't exist in a vacuum. They're woven into your comprehensive Mend health strategy alongside hormone panels, metabolic testing, and biomarker analysis.

Concierge Follow-Up

If a cancer signal is detected, you're not left navigating the healthcare system alone. Your Mend provider coordinates immediate next steps, specialist referrals, and follow-up imaging.

FAQ

Common Questions

Early Detection Could Save Your Life

Most cancers caught early have significantly higher survival rates. Don't wait for symptoms. Screen proactively with the most advanced multi-cancer blood test available.

HSA / FSA Eligible
Results in ~2 Weeks
Reviewed by Your Mend Physician
CLIA-Certified Laboratory